Ablelite Pediatric Device Clinical Study

Status Not yet recruiting

Clinical Trial Summary

The primary objective of the AbleLite early feasibility study is to evaluate the function of the upper limbs of participants diagnosed with neuromuscular disorders as children, with and without use of the Abilitech AbleLite device in the clinic and home environments. Functional outcomes will include documenting active range of motion and the ability to perform activities of daily living (ADLs) using the standardized Canadian Occupational Performance Measure (COPM) and the Role Evaluation of Activities of Life (REAL) assessments. Secondary objectives are to assess the safety record and report on adverse events (AEs) and parameters related to device usage, including device usage time and the time required to don/doff the device.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscular Dystrophies

Clinical Trial Details

NCT number	NCT04308447
Study type	Interventional
Source	AbiliTech Medical Inc.
Contact	Director of Clinical and Product Management
Phone	833.225.3123
Email	info@abilitechmedical.com
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2020
Completion date	January 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01480245` - Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy	Phase 3
Completed	`NCT01153932` - Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy	Phase 2
Completed	`NCT00027391` - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT03851107` - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities	N/A
Completed	`NCT01462292` - A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)	Phase 2
Recruiting	`NCT06094205` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	N/A
Recruiting	`NCT05724173` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Active, not recruiting	`NCT03811301` - [BrainConnexion] - Neurodevice Phase I Trial	N/A
Completed	`NCT05881122` - Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability	N/A
Completed	`NCT04154098` - Evaluation of a Textile Scapula Orthosis	N/A
Recruiting	`NCT05409079` - Schulze Muscular Dystrophy Ability Clinical Study	N/A
Enrolling by invitation	`NCT04009408` - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders	N/A
Active, not recruiting	`NCT00674843` - The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies	Phase 1
Recruiting	`NCT02109692` - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies	N/A
Active, not recruiting	`NCT04045158` - Diaphragm Ultrasound in Neuromuscular Disorders
Not yet recruiting	`NCT03508583` - Turkish Version of The Measure of Processes of Care (MPOC)
Terminated	`NCT01803412` - A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects	Phase 3
Completed	`NCT03406780` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 2